These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 391333)

  • 21. Angiotensin-converting enzyme inhibitors: pathogenic and therapeutic implications for arterial hypertension.
    Waeber B; Brunner HR; Wauters JP; Gavras H
    Adv Nephrol Necker Hosp; 1981; 10():111-33. PubMed ID: 6267906
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of captopril on arterial blood pressure, plasma renin activity and vasopressin concentration in sodium-repleted and sodium-deficient goats. A serial study during pregnancy, lactation and anestrus.
    Olsson K; Fyhrquist F; Benlamlih S; Dahlborn K
    Acta Physiol Scand; 1984 May; 121(1):73-80. PubMed ID: 6377825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive action of captopril in angiotensin-salt hypertension.
    Muirhead EE; Brooks B; Brosius WL
    Arch Pathol Lab Med; 1980 Dec; 104(12):631-4. PubMed ID: 7002102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
    Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
    Cohen ML; Kurz KD
    J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of captopril on blood pressure and renin-angiotensin-aldosterone system in hypertensive subjects after inhibition of renal vasodilative system.
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Giordano M; Gnecchi M; Trinchieri F; Ficara C
    Int J Clin Pharmacol Res; 1984; 4(1):41-5. PubMed ID: 6381343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of a single dose of captopril on arterial pressure, electrolytes and hormonal parameters. Study in 20 patients with long-term treatment in 8 patients].
    Guillevin L; Lardoux MD; Corvol P
    Rev Med Interne; 1981 Oct; 2(3):341-07. PubMed ID: 7027392
    [No Abstract]   [Full Text] [Related]  

  • 29. [Bartter's syndrome: effect of captopril on arterial pressure].
    Kohser F; Peter B; Imbs JL; Schwartz J
    Nouv Presse Med; 1981 Feb; 10(6):429. PubMed ID: 7012792
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension.
    Iseki K; Onoyama K; Fujimi S; Fukiyama K; Omae T
    Clin Nephrol; 1982 Mar; 17(3):149-54. PubMed ID: 7039897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chronic intrarenal prostaglandin E2 infusion and angiotensin II blockade on arterial pressure in the dog.
    Hockel GM; Cowley AW
    Adv Prostaglandin Thromboxane Res; 1980; 7():1061-5. PubMed ID: 6989177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antihypertensive effect of captopril in patients with mild or moderate systemic arterial hypertension].
    Savioli RM; Lima EV; Estrella LA; Puppi EJ; Praxedes JN; Nassif M; Stoeber GH; Del Nero Júnior E
    Arq Bras Cardiol; 1984 Jan; 42(1):67-71. PubMed ID: 6378150
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of mild and moderate arterial hypertension with low doses of captopril].
    Alves Filho G; Santos TC; Carvalho OM; Guariento ME; Rizzalitti F; Rocha JC
    Arq Bras Cardiol; 1984 May; 42(5):377-80. PubMed ID: 6391438
    [No Abstract]   [Full Text] [Related]  

  • 34. [Captopril].
    Belovezhov N
    Vutr Boles; 1981; 20(6):30-4. PubMed ID: 7039126
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of the antihypertensive effect of captopril induced by prostaglandin synthetase inhibition.
    Covi G; Minuz P; Capuzzo G; Lechi C; Delva P; Lechi A
    Int J Clin Pharmacol Res; 1984; 4(1):47-52. PubMed ID: 6432714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Angiotensin converting enzyme--captopril].
    Kaneko Y; Shionoiri H; Uneda S; Fujishima S
    Nihon Rinsho; 1979 Oct; 37(10):3492-8. PubMed ID: 392136
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood pressure regulation by angiotensin in the spontaneously hypertensive rats.
    Sokabe H; Kawashima K; Watanabe TX
    Adv Exp Med Biol; 1979; 120B():429-35. PubMed ID: 390989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypertensive crisis. Treatment with captopril after failure with a diuretic. Multicenter study].
    Saragoça M; Ribeiro AB; Ramos OL
    Arq Bras Cardiol; 1982 May; 38(5):415-9. PubMed ID: 6762867
    [No Abstract]   [Full Text] [Related]  

  • 39. First dose effect of the oral angiotensin converting enzyme inhibitor captopril.
    Fagard R; Amery A; Lijnen P; Staessen J
    Arch Int Pharmacodyn Ther; 1980; Suppl():178-87. PubMed ID: 6251761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of sodium status in the control of blood pressure: studies in anephric patients and in renal hypertensives.
    Deheneffe J; Cuesta V; Brown JJ; Lever AF; Morton JJ; Oelkers W; Robertson JI
    Acta Clin Belg; 1977; 32(3):183-90. PubMed ID: 602607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.